Game On, page-219

@RealRockerfeller :- I can tell RAP is in your contingency plan to make up for losses, otherwise you wouldn't show up here like full moon .

If you wait long enough you will find RAP will be filing FDA not for one but for multiple diseases. You will also find that it will suitable not only B2B but also B2C. Also it will work on multiple platforms.

Don't tell me you are here to tell FIL and others that they don't know what they are doing. I am sure they have some bright sparks on their pay roll to do due diligence instead of reading your post st HC.

FYI - Almost 40% is held by top 20 and list hasn't changed much in last 12 months.

Good luck if you buy in if Not already done so !